RVMD Overview
Upcoming Projects (RVMD)
-
Analyzing Phase 1/1b Results for Revolution Medicines' (RVMD) RMC-6236 in PDAC and NSCLC
Ticker: RVMD
Execute By: Mar 31, 2025
Executed Projects (RVMD)
-
A Second View: Looking at Revolution Medicine's RMC-6236 and the results to date prior to their RASolute 302 Phase 3 Trial
Ticker: RVMD
Executed On: Aug 07, 2024 at 04:00 PM EDT -
Looking at Revolution Medicine's RMC-6236 and the results to date prior to their RASolute 302 Phase 3 Trial
Ticker: RVMD
Executed On: Jul 23, 2024 at 03:30 PM EDT
Expired Projects (RVMD)
-
Evaluating Revolution Medicines, Inc.'s RMC-6236 and RMC-6291 for the Treatment of Advanced Solid Tumors
Ticker: RVMD
Execute By: Nov 30, 2023
Upcoming & Overdue Catalysts (RVMD)
-
REVOLUTION Medicines'(RVMD) SHP2 (RMC-4630) to Report Phase 1 monotherapy dose escalation safety data in cancer, in 1H 2021
Ticker: RVMD
Future Window: Jan 01, 2021 - Jun 30, 2021
Overdue
Strategic Initiatives (RVMD)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
